Wedbush Reiterates Outperform on IDEAYA Biosciences, Maintains $52 Price Target

Benzinga ·  May 8 10:14

Wedbush analyst Robert Driscoll reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $52 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment